116 related articles for article (PubMed ID: 37658788)
1. Cheminformatics and systems pharmacology approaches to unveil the potential plant bioactives to combat COVID-19.
Muralitharan D; Varadharajan V; Venkidasamy B
J Mol Recognit; 2023 Oct; 36(10):e3055. PubMed ID: 37658788
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomics, Cheminformatics, and Systems Pharmacology Strategies Unveil the Potential Bioactives to Combat COVID-19.
Adarshan S; Akassh S; Avinash K; Bharathkumar M; Muthuramalingam P; Shin H; Baskar V; Chen JT; Bhuvaneshwari V; Ramesh M
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144690
[TBL] [Abstract][Full Text] [Related]
3. Unlocking Prognostic Genes and Multi-Targeted Therapeutic Bioactives from Herbal Medicines to Combat Cancer-Associated Cachexia: A Transcriptomics and Network Pharmacology Approach.
Muthamil S; Muthuramalingam P; Kim HY; Jang HJ; Lyu JH; Shin UC; Go Y; Park SH; Lee HG; Shin H; Park JH
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203330
[TBL] [Abstract][Full Text] [Related]
4. Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach.
Muthuramalingam P; Jeyasri R; Valliammai A; Selvaraj A; Karthika C; Gowrishankar S; Pandian SK; Ramesh M; Chen JT
Genomics; 2020 Nov; 112(6):4486-4504. PubMed ID: 32771622
[TBL] [Abstract][Full Text] [Related]
5. Integrated omics profiling and network pharmacology uncovers the prognostic genes and multi-targeted therapeutic bioactives to combat lung cancer.
Muthuramalingam P; Akassh S; Rithiga SB; Prithika S; Gunasekaran R; Shin H; Kumar R; Baskar V; Kim J
Eur J Pharmacol; 2023 Feb; 940():175479. PubMed ID: 36566006
[TBL] [Abstract][Full Text] [Related]
6.
Adarshan S; Muthuramalingam P; Jeyasri R; Lakshmi MA; Sathishkumar R; Pandian SK; Shin H; Chen JT; Ramesh M
Front Biosci (Landmark Ed); 2022 Mar; 27(3):87. PubMed ID: 35345319
[TBL] [Abstract][Full Text] [Related]
7.
Jeyasri R; Muthuramalingam P; Suba V; Ramesh M; Chen JT
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32252235
[TBL] [Abstract][Full Text] [Related]
8.
Rolta R; Yadav R; Salaria D; Trivedi S; Imran M; Sourirajan A; Baumler DJ; Dev K
J Biomol Struct Dyn; 2021 Nov; 39(18):7017-7034. PubMed ID: 32851912
[TBL] [Abstract][Full Text] [Related]
9. Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking.
Li J; Huang Z; Lu S; Luo H; Tan Y; Ye P; Liu X; Wu Z; Wu C; Stalin A; Wang H; Liu Y; Shen L; Fan X; Zhang B; Yi J; Yao L; Xu Y; Wu J; Duan X
Medicine (Baltimore); 2021 Dec; 100(51):e27112. PubMed ID: 34941025
[TBL] [Abstract][Full Text] [Related]
10. Exploring Anti-osteoporosis Medicinal Herbs using Cheminformatics and Deep Learning Approaches.
Lin Z; Wang S; Liu Z; Liu B; Xie L; Zhou J
Comb Chem High Throughput Screen; 2023; 26(9):1802-1811. PubMed ID: 36065918
[TBL] [Abstract][Full Text] [Related]
11. In silico screening of potential anti-COVID-19 bioactive natural constituents from food sources by molecular docking.
Xu J; Gao L; Liang H; Chen SD
Nutrition; 2021 Feb; 82():111049. PubMed ID: 33290972
[TBL] [Abstract][Full Text] [Related]
12. Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
Singh M; Jindal D; Kumar R; Pancham P; Haider S; Gupta V; Mani S; R R; Tiwari RK; Chanda S
J Alzheimers Dis; 2023; 93(2):705-726. PubMed ID: 37066913
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Mechanism of Xiaoqinglong Decoction against COVID-19 Based on Network Pharmacology and Molecular Docking Technology.
Li HL; Zhou JP; Deng JM
Comb Chem High Throughput Screen; 2022; 25(13):2264-2277. PubMed ID: 35227178
[TBL] [Abstract][Full Text] [Related]
14. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
15. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
Murugesan S; Kottekad S; Crasta I; Sreevathsan S; Usharani D; Perumal MK; Mudliar SN
Comput Biol Med; 2021 Sep; 136():104683. PubMed ID: 34329860
[TBL] [Abstract][Full Text] [Related]
16. Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach.
Thirumal Kumar D; Shree Devi MS; Udhaya Kumar S; Sherlin A; Mathew A; Lakshmipriya M; Sathiyarajeswaran P; Gnanasambandan R; Siva R; Magesh R; George Priya Doss C
Adv Protein Chem Struct Biol; 2022; 129():275-379. PubMed ID: 35305722
[TBL] [Abstract][Full Text] [Related]
17. Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study.
Kar B; Dehury B; Singh MK; Pati S; Bhattacharya D
J Mol Graph Model; 2022 Jul; 114():108192. PubMed ID: 35468453
[TBL] [Abstract][Full Text] [Related]
18. Neem and Turmeric in the management of Covid Associated Mucormycosis (CAM) derived through network pharmacology.
Datta S; Sarkar I; Sen G; Sen A
J Biomol Struct Dyn; 2023 May; 41(8):3281-3294. PubMed ID: 35253616
[TBL] [Abstract][Full Text] [Related]
19. Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach.
Ogidigo JO; Iwuchukwu EA; Ibeji CU; Okpalefe O; Soliman MES
J Biomol Struct Dyn; 2022 Mar; 40(5):2284-2301. PubMed ID: 33103616
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Potential Mechanism of Action of Ursolic Acid against Gastric Cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
